Nucleai
nucleai.aiLocations
North Chicago, IL, USA · Chicago, IL, USA
industry
Biotechnology · Blockchain and Crypto · Data and Analytics · DeepTech · Health · Information Technology · Software
Size
51-200 employees
Stage
Other
founded in
2018
Nucleai Brings AI-powered spatial biology technology to the forefront of precision medicine to improve drug development, clinical treatment decisions, and patient outcomes. Nucleai works with leading pharmaceutical companies, licensing its research platform for internal use, and collaborating in biomarkers discovery projects. Nucleai’s Atom: The leading Spatial Biology Platform for Precision Medicine.
Something looks off?Open jobs at Nucleai